title: Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula.
abstract: The habenular complex, encompassing medial (MHb) and lateral (LHb) divisions, is a highly conserved epithalamic structure involved in the dorsal diencephalic conduction system (DDC). These brain nuclei regulate information flow between the limbic forebrain and the mid- and hindbrain, integrating cognitive with emotional and sensory processes. The MHb is also one of the strongest expression sites for mu opioid receptors (MORs), which mediate analgesic and rewarding properties of opiates. At present however, anatomical distribution and function of these receptors have been poorly studied in MHb pathways. Here we took advantage of a newly generated MOR-mcherry knock-in mouse line to characterize MOR expression sites in the DDC. MOR-mcherry fluorescent signal is weak in the LHb, but strong expression is visible in the MHb, fasciculus retroflexus (fr) and interpeduncular nucleus (IPN), indicating that MOR is mainly present in the MHb-IPN pathway. MOR-mcherry cell bodies are detected both in basolateral and apical parts of MHb, where the receptor co-localizes with cholinergic and substance P (SP) neurons, respectively, representing two main MHb neuronal populations. MOR-mcherry is expressed in most MHb-SP neurons, and is present in only a subpopulation of MHb-cholinergic neurons. Intense diffuse fluorescence detected in lateral and rostral parts of the IPN further suggests that MOR-mcherry is transported to terminals of these SP and cholinergic neurons. Finally, MOR-mcherry is present in septal regions projecting to the MHb, and in neurons of the central and intermediate IPN. Together, this study describes MOR expression in several compartments of the MHb-IPN circuitry. The remarkably high MOR density in the MHb-IPN pathway suggests that these receptors are in a unique position to mediate analgesic, autonomic and reward responses.
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France.
authors.forename: O
authors.initials: O
authors.lastname: Gardon
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France.
authors.forename: L
authors.initials: L
authors.lastname: Faget
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France.
authors.forename: P
authors.initials: P
authors.lastname: Chu Sin Chung
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France.
authors.forename: A
authors.initials: A
authors.lastname: Matifas
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France.
authors.forename: D
authors.initials: D
authors.lastname: Massotte
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université de Strasbourg, 1 rue Laurent Fries, F-67404 Illkirch, France. Electronic address: brigitte.kieffer@douglas.mcgill.ca.
authors.forename: B L
authors.initials: BL
authors.lastname: Kieffer
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D004745:Enkephalins / Q000378:metabolism; D005260:Female; D055879:Gene Knock-In Techniques; D019262:Habenula / Q000378:metabolism*; D007150:Immunohistochemistry; D066268:Interpeduncular Nucleus / Q000378:metabolism*; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D008297:Male; D057507:Mice, 129 Strain; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009434:Neural Pathways / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000235:genetics / Q000378:metabolism*; D013373:Substance P / Q000378:metabolism; D000097573:Red Fluorescent Protein
chemical_list: D000109:Acetylcholine; D004745:Enkephalins; D008164:Luminescent Proteins; D011498:Protein Precursors; D017450:Receptors, Opioid, mu; D013373:Substance P; D000097573:Red Fluorescent Protein; C033660:preproenkephalin
keywords: acetylcholine; interpeduncular nucleus; knock-in mice; medial habenula; mu opioid receptor; substance P
references.citation: Neuron. 2013 May 8;78(3):537-44
references.pmid: 23602500
references.citation: Trends Neurosci. 2013 Mar;36(3):195-206
references.pmid: 23219016
references.citation: Neurosci Lett. 1993 Jun 25;156(1-2):135-40
references.pmid: 7692360
references.citation: Neuroscience. 2009 Jul 7;161(3):827-37
references.pmid: 19362132
references.citation: Cold Spring Harb Perspect Med. 2013 Jun 01;3(6):
references.pmid: 23732854
references.citation: J Neurosci. 2011 Sep 14;31(37):13068-77
references.pmid: 21917790
references.citation: Eur J Neurosci. 2011 May;33(10):1885-96
references.pmid: 21395868
references.citation: PLoS One. 2011 Apr 29;6(4):e19450
references.pmid: 21559387
references.citation: J Comp Neurol. 2013 Feb 15;521(3):558-88
references.pmid: 22806483
references.citation: Neuroscience. 1999;91(1):81-105
references.pmid: 10336062
references.citation: Physiol Behav. 1996 Sep;60(3):845-53
references.pmid: 8873261
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5167-72
references.pmid: 16549786
references.citation: J Comp Neurol. 2009 Apr 20;513(6):597-621
references.pmid: 19235223
references.citation: Neuropharmacology. 2009;56 Suppl 1:205-12
references.pmid: 18718480
references.citation: Nat Rev Neurosci. 2010 Jul;11(7):503-13
references.pmid: 20559337
references.citation: Philos Trans R Soc Lond B Biol Sci. 2009 Apr 12;364(1519):1005-20
references.pmid: 19064356
references.citation: Neuropharmacology. 2002 Dec;43(8):1258-68
references.pmid: 12527475
references.citation: Neuroscience. 2012 Sep 27;221:203-13
references.pmid: 22750239
references.citation: J Comp Neurol. 2009 Mar 10;513(2):173-87
references.pmid: 19123238
references.citation: Eur J Pharmacol. 2005 Nov 21;525(1-3):98-104
references.pmid: 16289028
references.citation: Front Hum Neurosci. 2014 Jan 17;7:931
references.pmid: 24478666
references.citation: Nat Rev Neurosci. 2010 Jun;11(6):389-401
references.pmid: 20485364
references.citation: J Comp Neurol. 1988 Sep 1;275(1):117-27
references.pmid: 3170787
references.citation: Neuroscience. 2010 Jun 30;168(2):463-76
references.pmid: 20353812
references.citation: Neuropsychopharmacology. 2013 Nov;38(12):2418-26
references.pmid: 23736315
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):609-25
references.pmid: 17086392
references.citation: Learn Mem. 2011 Aug 18;18(9):574-8
references.pmid: 21852432
references.citation: Neuron. 2011 Feb 10;69(3):445-52
references.pmid: 21315256
references.citation: Neurosci Biobehav Rev. 1982 Spring;6(1):1-13
references.pmid: 7041014
references.citation: Eur J Neurosci. 2007 Jun;25(11):3398-405
references.pmid: 17553008
references.citation: Nature. 2000 May 11;405(6783):180-3
references.pmid: 10821273
references.citation: Brain Res. 1997 Dec 5;778(1):73-88
references.pmid: 9462879
references.citation: J Neurosci. 2001 Nov 15;21(22):RC181
references.pmid: 11698619
references.citation: Alcohol Clin Exp Res. 2006 Sep;30(9):1451-65
references.pmid: 16930207
references.citation: J Comp Neurol. 2012 Dec 15;520(18):4051-66
references.pmid: 22700183
references.citation: J Neurosci. 2014 Mar 19;34(12):4273-84
references.pmid: 24647947
references.citation: J Comp Neurol. 1994 Dec 15;350(3):412-38
references.pmid: 7884049
references.citation: Brain Res. 2002 Jul 26;945(1):9-19
references.pmid: 12113946
references.citation: Neuropsychopharmacology. 2012 Apr;37(5):1288-96
references.pmid: 22218090
references.citation: Neurosci Biobehav Rev. 2013 Sep;37(8):1801-9
references.pmid: 23876287
references.citation: J Comp Neurol. 2009 Apr 20;513(6):566-96
references.pmid: 19235216
references.citation: Neurosci Biobehav Rev. 2010 Nov;35(2):129-50
references.pmid: 20149820
references.citation: Neuroscience. 2014 May 16;267:67-82
references.pmid: 24583035
references.citation: Front Behav Neurosci. 2013 Mar 12;7:17
references.pmid: 23487260
references.citation: Neurosci Biobehav Rev. 2007;31(5):658-72
references.pmid: 17379307
references.citation: J Comp Neurol. 2005 Mar 7;483(2):236-50
references.pmid: 15678472
references.citation: Prog Neurobiol. 2002 Apr;66(5):285-306
references.pmid: 12015197
references.citation: Neuropeptides. 2003 Dec;37(6):345-54
references.pmid: 14698677
references.citation: Biochem Biophys Res Commun. 1994 Dec 15;205(2):1438-44
references.pmid: 7802680
references.citation: Neuroscience. 1987 Apr;21(1):253-70
references.pmid: 2439945
references.citation: CNS Spectr. 2008 Jun;13(6):484-9
references.pmid: 18567972
references.citation: Brain Res. 1990 Dec 3;535(1):18-24
references.pmid: 2292024
references.citation: PLoS One. 2009;4(5):e5425
references.pmid: 19412545
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):283-8
references.pmid: 1714041
references.citation: Brain Res. 1990 Aug 6;524(2):213-8
references.pmid: 2292004
references.citation: Physiol Rev. 2009 Oct;89(4):1379-412
references.pmid: 19789384
references.citation: Brain Res. 1999 Feb 13;818(2):335-45
references.pmid: 10082819
references.citation: Pharmacol Rev. 2013 Sep 27;65(4):1257-317
references.pmid: 24076545
references.citation: J Comp Neurol. 1986 Jul 1;249(1):65-102
references.pmid: 2426312
references.citation: PLoS One. 2013 Jun 28;8(6):e65684
references.pmid: 23840355
references.citation: Nature. 1996 Oct 31;383(6603):819-23
references.pmid: 8893006
references.citation: Neuropharmacology. 1998 Dec;37(12):1545-52
references.pmid: 9886677
references.citation: Br J Pharmacol. 2002 May;136(1):37-48
references.pmid: 11976266
references.citation: Brain Res Bull. 1997;43(3):321-6
references.pmid: 9227843
references.citation: Neurosci Biobehav Rev. 1985 Winter;9(4):573-87
references.pmid: 2417173
references.citation: Brain Res Bull. 1990 Aug;25(2):271-84
references.pmid: 1699638
references.citation: Annu Rev Physiol. 2012;74:225-43
references.pmid: 22054239
references.citation: Neuroscience. 1991;42(3):739-55
references.pmid: 1720226
references.citation: Neuropeptides. 2005 Dec;39(6):559-67
references.pmid: 16289278
references.citation: Nature. 1996 Oct 10;383(6600):535-8
references.pmid: 8849726
references.citation: Science. 2004 Jun 25;304(5679):1983-6
references.pmid: 15218152
references.citation: Brain Struct Funct. 2015 Mar;220(2):677-702
references.pmid: 24623156
references.citation: J Neurosci. 2009 Feb 18;29(7):2272-82
references.pmid: 19228980
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2630-5
references.pmid: 9482938
references.citation: Br J Pharmacol. 2010 Jul;160(6):1443-52
references.pmid: 20590634
references.citation: J Neurosci. 2008 Nov 12;28(46):11825-9
references.pmid: 19005047
references.citation: Med Sci Monit. 2004 Nov;10(11):RA261-73
references.pmid: 15507867
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9691-6
references.pmid: 16766653
references.citation: J Pharmacol Exp Ther. 2005 Sep;314(3):1362-9
references.pmid: 15908510
references.citation: Brain Res Bull. 2014 Jan;100:22-8
references.pmid: 24157953
references.citation: J Comp Neurol. 1992 Feb 15;316(3):287-313
references.pmid: 1374435
references.citation: Peptides. 2014 Jan;51:15-25
references.pmid: 24512946
references.citation: Nat Neurosci. 2012 Jun 24;15(8):1105-7
references.pmid: 22729176
references.citation: Nature. 2012 Nov 8;491(7423):212-7
references.pmid: 23064228
references.citation: Neurosci Lett. 2003 Mar 13;339(1):53-6
references.pmid: 12618299
references.citation: Neuropharmacology. 2014 Jan;76 Pt B:204-17
references.pmid: 24035914
references.citation: J Comp Neurol. 2011 Dec 1;519(17):3456-69
references.pmid: 21800299
references.citation: Anesthesiology. 2012 Oct;117(4):847-56
references.pmid: 22913923